Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinic Toxin for Plantar Lesions in Localized Epidermolysis Bullosa Simplex
NCT03453632Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2018
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in epidermolysis bullosa simplex (EBS), sponsored by Centre hospitalier universitaire de Toulouse. Started Jun 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT03453632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03453632.